Product
Elizaria®
1 clinical trial
1 indication
Indication
Paroxysmal Nocturnal HemoglobinuriaClinical trial
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® in Patients With Paroxysmal Nocturnal Hemoglobinuria.Status: Completed, Estimated PCD: 2022-12-28